Nasal airflow, as measured by rhinomanometry, is frequently impaired in allergic rhinitis (AR). The decongestion test evaluates whether the application of an intranasal vasoconstrictor drug increases nasal airflow.The aim of this study was to define the characteristics of decongestion test responders.123 subjects (112 males and 11 females, mean age 22.9+/-5.7 years) with AR were studied. Nasal eosinophils, rhinomanometry, and decongestion test were assessed in all subjects.The optimal cut-off for \% variation of nasal airflow and nasal eosinophils >5 was = 34.4, with sensibility = 82.7\% (95\%CI 73.7-89.6) and specificity = 80\% (95\%CI 59.3-93.1).The clinical relevance of this study is that non-responders may have a likely moderate-severe allergic inflammation that should be adequately evaluated and treated.

Nasal decongestion test in allergic rhinitis: definition of responder.

CASTELLAZZI, ANNA MARIA;MARSEGLIA, GIAN LUIGI
2007-01-01

Abstract

Nasal airflow, as measured by rhinomanometry, is frequently impaired in allergic rhinitis (AR). The decongestion test evaluates whether the application of an intranasal vasoconstrictor drug increases nasal airflow.The aim of this study was to define the characteristics of decongestion test responders.123 subjects (112 males and 11 females, mean age 22.9+/-5.7 years) with AR were studied. Nasal eosinophils, rhinomanometry, and decongestion test were assessed in all subjects.The optimal cut-off for \% variation of nasal airflow and nasal eosinophils >5 was = 34.4, with sensibility = 82.7\% (95\%CI 73.7-89.6) and specificity = 80\% (95\%CI 59.3-93.1).The clinical relevance of this study is that non-responders may have a likely moderate-severe allergic inflammation that should be adequately evaluated and treated.
2007
Immunology incorporates cellular and molecular studies in immunology, as well as clinical research in immunopathology, infectious disease, autoimmunity, and allergy. Host-pathogen interactions in infectious disease, as well as experimental therapeutic applications of immunomodulating agents are also considered. Resources dealing primarily with the biology of microbial, viral, or parasitic pathogens are excluded and are covered in the Microbiology category.
Sì, ma tipo non specificato
Inglese
Internazionale
STAMPA
7
372
374
2
Adult, Eosinophils; drug effects, Female, Humans, Male, Nasal Decongestants; therapeutic use, Rhinitis; Allergic; Perennial; drug therapy/physiopathology, Rhinitis; Seasonal; drug therapy/physiopathology
http://dx.doi.org/10.1016/j.intimp.2006.11.009
6
info:eu-repo/semantics/article
262
G., Ciprandi; I., Cirillo; C., Klersy; Castellazzi, ANNA MARIA; S., Barberi; Marseglia, GIAN LUIGI
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/452814
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 13
social impact